文献速递间质性肺疾病

转录组数据集聚类分析识别特发性肺纤维化内型

Cluster analysis of transcriptomic datasets to identify endotypes of idiopathic pulmonary fibrosis.
PubMed 文献 · Thorax · 2022-05-09

研究对三个公开血液转录组数据集(共220例IPF)进行共归一化、合并和聚类,识别出三个临床特征有差异的IPF患者聚类,并开发验证了一个13基因分类器预测死亡风险(高风险聚类vs低风险聚类:HR 4.25,95%CI 2.14-8.46,p=3.7×10-5)。

要点

  • IPF患者血液转录组可聚类为三个组,组间肺功能(p=0.009)和死亡率(p=0.009)差异显著。
  • 13基因分类器在独立数据集中验证可预测IPF死亡风险(HR 4.25)。
  • 聚类涉及线粒体稳态、凋亡、细胞周期和免疫通路,支持IPF多内型假说。

核心结论

  • 血液基因表达特征可区分IPF患者中生存差异显著的组别,支持IPF存在多个内型。
  • 13基因分类器可能有助于IPF患者分层和结局预测。

研究设计与样本

  • 对三个公开血液转录组数据集(共220例IPF)进行共归一化、合并和聚类分析。
  • 在三个额外独立数据集(共194例IPF)中开发并验证基于基因的分类器。

主要发现

  • 识别出三个IPF患者聚类,组间肺功能差异p=0.009,死亡率差异p=0.009。
  • 基因富集分析涉及线粒体稳态、凋亡、细胞周期及先天性和适应性免疫。
  • 13基因分类器预测IPF死亡率:高风险聚类vs低风险聚类HR 4.25,95%CI 2.14-8.46,p=3.7×10-5。

关键数值与推荐

  • 聚类间肺功能差异p=0.009,死亡率差异p=0.009(220例IPF)。
  • 13基因分类器预测死亡风险HR 4.25,95%CI 2.14-8.46,p=3.7×10-5(验证集194例IPF)。

临床怎么用

  • 血液基因表达分类器可用于IPF患者风险分层和结局预测,辅助个体化管理。

局限性

  • 需更多工作确认这些内型的存在。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Considerable clinical heterogeneity in idiopathic pulmonary fibrosis (IPF) suggests the existence of multiple disease endotypes. Identifying these endotypes would improve our understanding of the pathogenesis of IPF and could allow for a biomarker-driven personalised medicine approach. We aimed to identify clinically distinct groups of patients with IPF that could represent distinct disease endotypes. METHODS: We co-normalised, pooled and clustered three publicly available blood transcriptomic datasets (total 220 IPF cases). We compared clinical traits across clusters and used gene enrichment analysis to identify biological pathways and processes that were over-represented among the genes that were differentially expressed across clusters. A gene-based classifier was developed and validated using three additional independent datasets (total 194 IPF cases). FINDINGS: We identified three clusters of patients with IPF with statistically significant differences in lung function (p=0.009) and mortality (p=0.009) between groups. Gene enrichment analysis implicated mitochondrial homeostasis, apoptosis, cell cycle and innate and adaptive immunity in the pathogenesis underlying these groups. We developed and validated a 13-gene cluster classifier that predicted mortality in IPF (high-risk clusters vs low-risk cluster: HR 4.25, 95% CI 2.14 to 8.46, p=3.7×10-5). INTERPRETATION: We have identified blood gene expression signatures capable of discerning groups of patients with IPF with significant differences in survival. These clusters could be representative of distinct pathophysiological states, which would support the theory of multiple endotypes of IPF. Although more work must be done to confirm the existence of these endotypes, our classifier could be a useful tool in patient stratification and outcome prediction in IPF.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Kraven LM, Taylor AR, Molyneaux PL, et al. Cluster analysis of transcriptomic datasets to identify endotypes of idiopathic pulmonary fibrosis. Thorax. 2022. PMID: 35534152. doi:10.1136/thoraxjnl-2021-218563

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。